Pancreatic Cancer Research

ResearcherUniversity of IowaNo recent work listed

John A. Cieslak

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7507-5037; OpenAlex author ID A5024617607. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2014: 1 paper · 2015: 3 papers

Papers 4

  1. Manganoporphyrins and ascorbate enhance gemcitabine cytotoxicity in pancreatic cancer. Co-author DOI 10.1016/j.freeradbiomed.2015.02.018↗
  2. Pharmacological Ascorbate Radiosensitizes Pancreatic Cancer. First author DOI 10.1158/0008-5472.can-14-1707↗
  3. Treatment of Pancreatic Cancer with Pharmacological Ascorbate. Co-author DOI 10.2174/138920101609150715135921↗
  4. Extracellular superoxide dismutase suppresses hypoxia-inducible factor-1α in pancreatic cancer. Co-author DOI 10.1016/j.freeradbiomed.2014.02.002↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Joseph J. Cullen · 4 shared papers, 2014–2015 · strength 0.23
  2. Garry R. Buettner · 3 shared papers, 2014–2015 · strength 0.13
  3. Juan Du · 3 shared papers, 2014–2015 · strength 0.13
  4. Jessemae L. Welsh · 2 shared papers, 2014–2015 · strength 0.08
  5. Prabhat C. Goswami · 2 shared papers, 2014–2015 · strength 0.08
  6. Zita A. Sibenaller · 2 shared papers, 2014–2015 · strength 0.08
  7. Douglas Robert Spitz · 1 shared paper, 2015 · strength 0.04
  8. James J. Mezhir · 1 shared paper, 2015 · strength 0.04
  9. Bryan G. Allen · 1 shared paper, 2015 · strength 0.04
  10. Susan Tsai · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.